PMC:7252011 / 175-568
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 15 | 63-71 | Species | denotes | patients | Tax:9606 |
| 16 | 338-348 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 19 | 3-11 | Disease | denotes | Covid-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 264-272 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 237-247 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T2 | 338-346 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 349-352 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T3 | 353-354 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 381-392 | Chemical | denotes | Angiotensin | http://purl.obolibrary.org/obo/CHEBI_2719 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 273-288 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 3-154 | Sentence | denotes | Covid-19 is characterized by weak symptoms in most affected patients whilst severe clinical complications, with frequent fatal issues, occur in others. |
| T5 | 155-213 | Sentence | denotes | Disease severity is associated with age and comorbidities. |
| T6 | 214-337 | Sentence | denotes | Understanding of viral infectious mechanisms, and antibody immune response, can help to better control disease progression. |